Despite the importance of the MDM2-MYCN axis in neuroblastoma and retinoblastoma, it has been unclear if MDM2 promotes MYCN expression in additional cancers and if MDM2 also regulates MYC. This evidence concerns the gene MYC and neuroblastoma.